Mechanisms of NKT Cell Anergy Induction Involve Cbl-b-promoted Monoubiquitination of CARMA1
Overview
Affiliations
Repeated injection of alpha-galactosylceramide, an agonistic ligand for natural killer T (NKT) cells, results in long-term unresponsiveness or anergy, which severely limits its clinical application. However, the molecular mechanisms leading to NKT anergy induction remain unclear. We show here that the decreased IFN-gamma production and failed tumor rejection observed in anergized NKT cells are rescued by Cbl-b deficiency. Cbl-b E3 ligase activity is critical for the anergy induction, as revealed by the similarity between Cbl-b(-/-) and its RING finger mutant NKT cells. Cbl-b binds and promotes monoubiquitination to CARMA1, a critical signaling molecule in NFkappaB activation. Ubiquitin conjugation to CARMA1 disrupts its complex formation with Bcl10 without affecting its protein stability. In addition, CARMA1(-/-) NKT cells are defective in IFN-gamma production. The study identifies an important signaling pathway linking Cbl-b-induced monoubiquitination to NFkappaB activation in NKT cell anergy induction, which may help design approaches for human cancer therapy.
Nath P, Isakov N Life (Basel). 2025; 14(12.
PMID: 39768300 PMC: 11677474. DOI: 10.3390/life14121592.
The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategies.
Ren J, Lv L, Tao X, Zhai X, Chen X, Yu H Front Pharmacol. 2024; 15:1432545.
PMID: 39130630 PMC: 11310040. DOI: 10.3389/fphar.2024.1432545.
Sada M, Matsushima S, Ikeda M, Ikeda S, Okabe K, Ishikita A JACC Basic Transl Sci. 2023; 8(8):992-1007.
PMID: 37719427 PMC: 10504401. DOI: 10.1016/j.jacbts.2023.02.014.
Glutaminolysis and peripheral CD4 T cell differentiation: from mechanism to intervention strategy.
Liu T, Ren S, Sun C, Zhao P, Wang H Front Immunol. 2023; 14:1221530.
PMID: 37545506 PMC: 10401425. DOI: 10.3389/fimmu.2023.1221530.
Targeting Cbl-b in cancer immunotherapy.
Augustin R, Bao R, Luke J J Immunother Cancer. 2023; 11(2).
PMID: 36750253 PMC: 9906388. DOI: 10.1136/jitc-2022-006007.